Biology Reference
In-Depth Information
Francis SH, Lincoln TM, Corbin JD (1980) Characterization of a novel cGMP binding protein
from rat lung. J Biol Chem 255:620-626
Frossard N, Landry Y, Pauli G, Ruckstuhl M (1981) Effects of cyclic AMP- and cyclic
GMP-phosphodiesterase inhibitors on immunological release of histamine and lung contrac-
tion. Br J Pharmacol 73:933-938
Fuhrmann M, Jahn HU, Seybold J, Neurohr C, Barnes PJ, Hippenstiel S, Kraemer HJ, Suttorp N
(1999) Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in
airway epithelial cells. Am J Respir Cell Mol Biol 20:292-302
Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A (1997a) In vitro differentiation
of human monocytes to macrophages: change of PDE profile and its relationship to suppression
of tumour necrosis factor-
a
release by PDE inhibitors. Br J Pharmacol 121:221-231
Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A (1997b) Phosphodiesterase
profiles of highly purified human peripheral blood leukocyte populations from normal and
atopic individuals: a comparative study. J Allergy Clin Immunol 100:527-537
Gantner F, Schudt C, Wendel A, Hatzelmann A (1999) Characterization of the phosphodiesterase
(PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE
inhibitors on DC functions. Pulm Pharmacol Ther 12:377-386
Ghofrani HA, Wiedemann R, Rose F, Olschewki H, Schermuly RT, Weissmann N, Seeger W,
Grimminger F (2002a) Combination therapy with oral sildenafil and inhaled ileprost for severe
pulmonary hypertension. Ann Intern Med 136:515-522
Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Weissmann N, Schudt C,
Tenor H, Seeger W, Grimminger F (2002b) Amplification of the pulmonary vasodilatory
response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in
severe pulmonary hypertension. Crit Care Med 30:2489-2492
Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: from angina to erectile dysfunction to
pulmonary hypertension and beyond. Nature Rev 5:689-702
Giembycz MA, Field KF (2010) Roflumilast: first phosphodiesterase 4 inhibitor approved for
treatment of COPD. Drug Des Dev Ther 4:147-158
Giembycz MA, Corrigan CJ, Seybold J, Newton R, Barnes PF (1996) Identification of cyclic AMP
phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T- lymphocytes: role in regulating
proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 118:1945-1958
Goldie RG, Papadimitriou JM, Paterson JW, Rigby PJ, Self HM, Spina D (1986) Influence of
the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant
agonists. Br J Pharmacol 87:5-14
Greene JA, Paul WD (1937) The action of theophylline with ethylenediamine on intrathecal and
venous pressure in cardiac failure and on bronchial obstruction in cardiac failure an bronchial
asthma. J Am Med Assoc 109:1712
Grimminger F, Spriesterbach R, Weissmann N, Walmrath D, Seeger W (1995) Nitric oxide
generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J Appl Physiol
78:1509-1515
Grootendorst DC, Gauw SA, Baan R, Kelly J, Murdoch RD, Sterk PJ, Rabe KF (2003) Does
a single dose of the phosphodiesterase 4 inhibitor, cilomilast /15 mg), induce bronchodilation
in patients with chronic obstructive pulmonary disease? Pulm Pharmacol Ther 16:115-129
Grueter R (1910)
Uber leicht losliche Verbindungen des Theophyllins. Therapeutische Monat-
shefte 24:613
Hamilton TC (1972) The effects of some phosphodiesterase inhibitors on the conductance of the
perfused vascular beds of the chloralosed cat. Br J Pharmacol 46:386-394
Hannon JP, Tigani B, Williams I, Mazzoni L, Fozard JR (2001) Mechanism of airway hyperre-
sponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway
rats. Br J Pharmacol 132:1509-1523
Hargreave FE (1989) Late-phase asthmatic responses and airway inflammation. J Allergy Clin
Immunol 83:525-527
